Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 16

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 16
---
 by the independent auditor, in accordance with Section 10A of the Exchange Act and SEC rules. All services for which fees were billed as described above were pre-approved by the Audit Committee. None of the services described above were approved by the Audit Committee pursuant to the de minimis exception during the fiscal years ended March 31, 2025 and March 31, 2024. Vote Required You may vote “FOR,” “AGAINST,” or “ABSTAIN” on Proposal 3. The vote required to approve Proposal 3 is governed by Delaware law and our Bylaws and is the affirmative vote of the majority of votes cast on this Proposal. As a result, abstentions and broker non-votes will have no effect on the outcome of Proposal 3. If not otherwise specified, proxies will be voted “FOR” Proposal 3. THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE “ FOR” THE RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 31, 2026.

9

TABLE OF CONTENTS

INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE Director Nominees The following table sets out certain information regarding each of the nominees for election as director:

| Name               |     | Age |     | Title                                |     | First year as 
      director |
| Vimal Kavuru       |     |  56 |     | Director and Chair of the Board      |     |          2021 |
| A. Brian Davis     |     |  58 |     | Director                             |     |          2023 |
| S. George Kottayil |     |  62 |     | Director                             |     |          2023 |
| Prashant Kohli     |     |  53 |     | Director and Chief Executive Officer |     |          2023 |
| Edward Neugeboren  |     |  56 |     | Director                             |     |          2023 |

| • | The Audit Committee of the Board (the “Audit Committee”) is currently composed of Mr. Davis, as Chair, Mr. Kavuru and Mr. Neugeboren. |

| • | The Compensation Committee is currently composed of Mr. Kavuru, as Chair, Mr. Davis and Mr. Neugeboren. |

| • | The N